The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: pro

12 April 2026 (08:00 - 15:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Jarkko Karvonen

Helsinki University Hospital, Helsinki (Finland)

5 More presentations in this session

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: pro

Professor C. Sticherling (Basel, CH)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: con

Doctor N. Dagres (Berlin, DE)

Presentation thumbnail

Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: discussion

Presentation thumbnail

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con

Associate Professor G. Upadhyay (Chicago, US)

Presentation thumbnail

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: discussion

Access the full session

Session thumbnail

Debate on cardiac implantable electronic device therapy

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

You may be interested in

Congress Session

Debate on cardiac implantable electronic device therapy

Congress Session

Debates and controversies in selection of cardiac implantable electronic devices

Congress Presentation

The left bundle branch pacing-shock lead will become standard in implantable cardioverter-defibrillator therapy: con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources